secwatch / observer
8-K filed November 4, 2022, 7:59 PM ET ticker ADNT CIK 0001670541
earnings confidence high sentiment negative materiality 0.80

Adient reports FY22 net loss of $120M; Q4 adj EPS $0.53; extends credit facility to 2027

Adient plc

2022-FY EPS reported -$1.27 revenue$14,121,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Adient plc reported financial results for the fourth quarter and fiscal year ended September 30, 2022.

Period
the fourth quarter and fiscal year ended September 30, 2022
Result
reported results
Exact text from the filing
On November 4, 2022, Adient plc issued a news release announcing its financial results for the fourth quarter and fiscal year ended September 30, 2022. The news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Adient plc amended Amendment and Restatement with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (effective 2022-11-02).

Action
amendment
Agreement
credit facility
Counterparty
JPMorgan Chase Bank, N.A., as administrative agent and collateral agent
Effective
2022-11-02
Exact text from the filing
On November 2, 2022 (the “Restatement Date”), Adient US LLC, a Michigan limited liability company (the “Lead Borrower”), Adient plc, and the other Loan Parties (as defined in the Amended Credit Agreement (as defined below)) entered into an amendment and restatement agreement (the “Amendment and Restatement”), which amended and restated that certain Revolving Credit Agreement, dated as of May 6, 2019
View on SEC.gov

Browse all earnings releases →

Adient plc filing history →

Source: SEC EDGAR
accession 0001670541-22-000090
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.